Develops a pill to slow vision loss from eye diseases.
No change
Duquesne owns 106,100 shares of Belite Bio, worth about $16 million. That’s less than $1 of every $100 they have in stocks. They didn’t really buy or sell any between April and June.
Mar 31
106,100
Jun 30
106,100
The numbers
Shares they own
106,100
Value on Jun 30, 2026
$16,338,000
about $16 million
Share of their money
0.4%
less than $1 of every $100 · 53rd of 85
Price per share on Jun 30
$153.99
Kind
Shares
Also owned by
No other fund we follow
More about Belite Bio ›
The value uses the price on Jun 30, 2026. The fund may have paid a different price.